Articles
11 June 2009
Vol. 3 No. 1: 2006...2009: Now we know T-cell lymphomas better, Bologna, Italy, 16-18 March 2009
https://doi.org/10.4081/hmr.v3i1.528

Gene expression profiling of peripheral T-cell lymphoma: from bench to bedside

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
235
Views
303
Downloads

Authors

PP Piccaluga
support@pagepress.org
M Rossi
A Gazzola
MR Sapienza
C Mannu
S Righi
C Agostinelli
MT Sista
SA Pileri
Peripheral T-cell lymphomas (PTCLs) represent approximately 12% of lymphoid neoplasms (1). Their incidence varies among countries, being higher in HTLV-1 endemic areas, such as Southern Japan, Caribbean basin and some USA districts.1 PTCLs are a heterogeneous group of tumors that can be roughly subdivided into specified and not otherwise specified (NOS) forms.2 While the former correspond to distinct but rare entities, often occurring at extra-nodal sites, the latter represent the commonest type of T-cell lymphoma (40-50% of cases), followed by the angioimmunoblastic (AITL) and anaplastic large cell (ALCL) ones.

Altmetrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite



Gene expression profiling of peripheral T-cell lymphoma: from bench to bedside. (2009). Hematology Meeting Reports (formerly Haematologica Reports), 3(1). https://doi.org/10.4081/hmr.v3i1.528